NIH-funded research R15 grant

Investigating how tick proteins affect blood feeding and immune response

Official title: PLURIPOTENCY OF NOVEL TICK CYSTEINE PROTEASE INHIBITORS DURING HEMATOPHAGY

Funded at University of Southern Mississippi · NIH-10515240 · Data updated 2026-11-12

This study is looking at how proteins in tick saliva help ticks feed on animals by changing how the animal's immune system works, and it's aimed at finding ways to boost the immune response to better protect against ticks and the diseases they can spread.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Southern Mississippi
NIH-funded
Lab location1 site (Hattiesburg, United States)
Project startJuly 20, 2022
Project endJune 30, 2026
Funding year2022
Award (this year)$444,000
NIH project number1R15AI167013-01A1
Project IDNIH-10515240 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are frequently exposed to ticks, such as outdoor workers, hikers, or those living in endemic areas.

Less likely to help

Patients who do not have exposure to ticks or live in areas where tick-borne diseases are not prevalent may not benefit from this research.

What this research studies

This research focuses on understanding how certain proteins in tick saliva help ticks feed on their hosts by manipulating the host's immune system. The study will explore three specific proteins from the Amblyomma maculatum tick and how they interact with the host's immune response during blood feeding. By using advanced techniques like RNA interference, researchers aim to uncover the role of these proteins in tick feeding and the transmission of diseases. The ultimate goal is to develop strategies that could enhance the host's immune response against these tick proteins.

Why it matters

Potential benefit: If successful, this research could lead to new methods for preventing tick-borne diseases by enhancing the immune response in humans and animals.

How similar studies have gone: Previous research has shown promise in understanding tick-host interactions, but this specific approach using novel cysteine protease inhibitors is relatively novel.

Where this research is happening

  • University of Southern Mississippi
    Hattiesburg, United States
    Active

Researchers

  • Principal investigator: Morgan, Sarah E — University of Southern Mississippi
  • Study coordinator: Morgan, Sarah E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.